Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions-Reference-Cited by-同舟云学术

Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions

Published:2023-02-20 Issue:15 Volume:44 Page:1376-1376
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Frustaci Andrea¹^ORCID,Russo Matteo Antonio²,Chimenti Cristina³

Affiliation:

1. Cellular and Molecular Cardiology Lab, IRCCS L. Spallanzani , Via Portuense, 00149 Rome , Italy

2. MEBIC Consortium, San Raffaele Open University and IRCCS San Raffaele Roma , Via Val Cannuta, 247 00166 Rome , Italy

3. Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome , Via Val Cannuta, 247 00166 Rome , Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/15/1376/49941806/ehad069.pdf

Reference4 articles.

1. Cell death, proliferation, and repair in human myocarditis responding to immunosuppressive therapy;Frustaci;Mod Pathol,2006

2. Atrogin-1 pathway activation in cushing syndrome cardiomyopathy;Frustaci;J Am Coll Cardiol,2016

3. Cushing syndrome cardiomyopathy: clinicopathologic impact of cortisol normalization;Frustaci;Circ Cardiovasc Imaging,2016

4. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study;Frustaci;Eur Heart J,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction to: Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions;European Heart Journal;2024-03-28

2. Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding;European Heart Journal;2023-04-14